EdgeRock Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.26M Buy
4,952
+1,264
+34% +$295K 0.28% 44
2026
Q1
$902K Buy
3,688
+267
+8% +$62.2K 0.24% 41
2025
Q4
$708K Buy
3,421
+267
+8% +$52.8K 0.19% 54
2025
Q3
$585K Buy
3,154
+442
+16% +$75.7K 0.16% 62
2025
Q2
$421K Buy
+2,712
New +$417K 0.13% 66
2023
Q4
Sell
-1,747
Closed -$272K 341
2023
Q3
$272K Buy
+1,747
New +$288K 0.17% 47
2023
Q2
Sell
-1,302
Closed -$202K 66
2023
Q1
$202K Buy
1,302
+151
+13% +$24.4K 0.1% 65
2022
Q4
$203K Sell
1,151
-28
-2% -$4.83K 0.11% 58
2022
Q3
$193K Sell
1,179
-294
-20% -$49.8K 0.11% 58
2022
Q2
$261K Buy
+1,473
New +$262K 0.18% 40

Other funds holding JNJ

EdgeRock Capital's JNJ Position: Q2 2026 in Review

EdgeRock Capital increased its Johnson & Johnson (JNJ) stake by 34% in Q2 2026, buying an estimated $295K and bringing the position to 4,952 shares worth $1.26M. The position accounts for 0.28% of the portfolio, ranked #44.

EdgeRock Capital first reported a position in JNJ in Q2 2022 and has held it in 10 quarters since. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • EdgeRock Capital held 4,952 shares of Johnson & Johnson worth $1.26M as of Q2 2026.
  • EdgeRock Capital bought 1,264 Johnson & Johnson shares in Q2 2026, an estimated $295K.
  • Johnson & Johnson made up 0.28% of EdgeRock Capital's portfolio in Q2 2026, its #44 holding.
  • EdgeRock Capital first reported a position in Johnson & Johnson in Q2 2022 and has held it in 10 quarters since.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on EdgeRock Capital's 13F filing for Q2 2026, filed 24 Jul 2026.